Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …

Intravenous immunoglobulin (IVIg)—a preparation of polyclonal serum IgG pooled from
thousands of blood donors—has been used for nearly three decades, and is proving to be …

Background: Consensus guidelines on the definition, investigation, and treatment of chronic
inflammatory demyelinating polyradiculoneuropathy (CIDP) have been published (J …

Background Short-term studies suggest that intravenous immunoglobulin might reduce
disability caused by chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) but …

Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a
chronic progressive or relapsing and remitting disease that usually causes weakness and …

Human immunoglobulin prepared for intravenous administration (IGIV) has a number of
important uses in the treatment of disease. Some of these are in diseases for which …

Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) causes
progressive or relapsing weakness and numbness of the limbs, which lasts for at least two …

This multicenter, randomized, double‐blind, crossover trial compared a 6 week course of
oral prednisolone tapering from 60 mg to 10 mg daily with intravenous immunoglobulin …

Objective: To assess the evidence for the efficacy of IV immunoglobulin (IVIg) to treat
neuromuscular disorders. Methods: The MEDLINE, Web of Science, and EMBASE …

Clinical uses of intravenous immunoglobulin | Clinical and Experimental Immunology | Oxford
Academic Skip to Main Content Advertisement intended for healthcare professionals Oxford …